Clinical Trial Detail

NCT ID NCT04165330
Title Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sarcoma Oncology Research Center, LLC
Indications

lung small cell carcinoma

lung non-small cell carcinoma

sarcoma

Advanced Solid Tumor

Therapies

Anlotinib + Nivolumab

Age Groups: adult senior

No variant requirements are available.